Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
HEKMA is a pioneering company utilizing artificial intelligence to enhance the efficiency of clinical trials by optimizing patient recruitment, assessing trial feasibility, and fostering patient engagement.
Their comprehensive platform caters to a diverse audience, including contract research organizations (CROs), pharmaceutical sponsors, healthcare facilities, and patients, by integrating electronic health records (EHRs) with AI-driven trial matching, clinical trial management solutions, and tools for engaging patients.
The core mission of HEKMA is to minimize delays in enrollment, broaden access to clinical trials—especially for underrepresented communities—and streamline the clinical research process to ensure it is more efficient, transparent, and centered around patient needs.
With a blend of healthcare knowledge, artificial intelligence capabilities, and clinical operations expertise, HEKMA adheres to crucial industry regulations such as HIPAA, 21 CFR Part 11, GDPR, and HL7/FHIR, ensuring the highest standards of compliance.
By harnessing innovative technology, HEKMA aims to transform the landscape of clinical trials, ultimately contributing to advancements in medical research and patient care.
Description
We are developing a worldwide marketplace for clinical trials aimed at enhancing visibility, accessibility, and involvement among a more varied group of healthcare professionals and their patients. At Inato, our goal is to ensure that clinical research is available to every patient, no matter their identity or location. Marketplaces have shown to be revolutionary in expanding access to various services, and we are convinced that we can replicate this success in the realm of clinical research. We illuminate the numerous community sites globally that are eager to provide additional trials for their patients, while also assisting them in realizing their full research capabilities. By effectively pairing the appropriate sites with suitable trials on an international scale, we streamline the process for all involved. Our comprehensive support model guarantees that sponsors can confidently collaborate with a diverse array of sites worldwide, thereby matching research locations to the ideal clinical trial protocols and unlocking their potential on a global stage. This approach not only benefits the sites and sponsors but ultimately enhances the experience and outcomes for patients participating in clinical trials.
API Access
Has API
No
API Access
Has API
No
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
No
In Person
Yes
Vendor Details
Company Name
HEKMA
Founded
2018
Country
United States
Website
www.hekma.ai/
Vendor Details
Company Name
Inato
Founded
2016
Country
France
Website
inato.com
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
No
Document Management
No
Electronic Data Capture
No
Enrollment Management
No
HIPAA Compliant
No
Monitoring
No
Patient Database
No
Recruiting Management
No
Scheduling
No
Study Planning
No
Product Features
Recruiting
Assessments
No
Background Screening
No
CRM
No
Interaction Tracking
No
Internal HR
No
Interview Management
No
Job Board Posting
No
Job Requisition
No
Onboarding
No
Recruiting Firms
No
Reference Checking
No
Resume Parsing
No
Self Service Portal
No